Skip to main content
SpringerLink
Log in

Grafikgestützter Konsensus für die Behandlung von Bewegungsstörungen bei Kindern mit bilateralen spastischen Zerebralparesen (BS-CP)

Therapiekurven – CP-Motorik

Graphically based Consensus on the treatment of movement disorders in children with bilateral spastic cerebral palsy (BS-CP)

Motor treatment curves in CP

  • Konsensuspapiere
  • Published:
Monatsschrift Kinderheilkunde Aims and scope Submit manuscript

Zusammenfassung

Unter der Federführung der Gesellschaft für Neuropädiatrie erarbeiteten die Fachgesellschaften für Neuropädiatrie, Sozialpädiatrie und Kinderorthopädie eine grafikgestützte Empfehlung für die Behandlung von Bewegungsstörungen bei Kindern mit bilateralen spastischen Zerebralparesen (BS-CP). Der vorliegende Konsensus wurde unter Einbindung der Neurowissenschaften und Rehabilitationsmedizin fertiggestellt. Der Konsensus „Therapiekurven-CP-Motorik“ hat das Ziel, alters- und schweregradbezogen Therapieoptionen zur Behandlung motorischer Störungen für Kinder mit BS-CP darzustellen. Als Grundlage dienen die GMFCS-Entwicklungskurven der Gruppe um Peter Rosenbaum, Kanada (www.canchild.ca). Die Therapie bedarf eines interdisziplinären, multimodalen Teams, das die individualisierten Therapiewege formuliert und umsetzt. Die Therapiekurven-CP-Motorik sollen den Ärzten, Therapeuten und Eltern helfen, die adäquaten Therapieoptionen auszuwählen und die Frage zu beantworten, welche Therapieoptionen wann, wie lange und in welchem Umfang begründet sind.

Abstract

An interdisciplinary group of German experts in the field of movement disorders was assembled under the auspices of the Society for Neuropediatrics to develop a graphically based guideline for a multidisciplinary treatment regime in the management of motor dysfunction in children with bilateral spastic cerebral palsy (BS-CP). The present consensus was accomplished by a cooperation including neuroscience and rehabilitation medicine. The aim of the “motor treatment curves in CP” is to present age- and severity-specific therapy options for the treatment of motor dysfunction in children with BS-CP on the basis of the GMFCS development curves from Peter Rosenbaum’s group in Canada (www.canchild.ca). An interdisciplinary team is required to set up and implement an optimal treatment plan for each individual patient. The motor treatment curves in CP are designed to help physicians, therapists and parents to choose the best therapy options and to decide when, for how long and to what extent therapy should be administered.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1

Literatur

  1. Anttila H, Autti-Ramo I, Suoranta J et al (2008) Effectiveness of physical therapy interventions for children with cerebral palsy: a systematic review. BMC Pediatr 8:14

    Article  PubMed  Google Scholar 

  2. Beweck S, Heinen F (2008) Cerebralparese. In: Heinen F, Berweck S, Fietzek U, Wissel J (eds) Blue box botulinumtoxin. Huber, Bern

  3. Blackmore AM, Boettcher-Hunt E, Jordan M et al (2007) A systematic review of the effects of casting on equinus in children with cerebral palsy: an evidence report of the AACPDM. Dev Med Child Neurol 49(10):781–790

    Article  PubMed  CAS  Google Scholar 

  4. Buonaguro V, Scelsa B, Curci D et al (2005) Epilepsy and intrathecal baclofen therapy in children with cerebral palsy. Pediatr Neurol 33(2):110–113

    Article  PubMed  Google Scholar 

  5. Cans C, Dolk H, Platt MJ et al (2007) Recommendations from the SCPE collaborative group for defining and classifying cerebral palsy. Dev Med Child Neurol [Suppl 109]:35–38

    Google Scholar 

  6. Damiano D (2004) Physiotherapy management of CP: moving beyond philosophies. In: Scrutton D, Damiano DJ, Mayston MJ (eds) Management of the motor disorders of the child with CP. Mac Keith Press, London, pp 161–169

  7. Davids JR, Rowan F, Davis RB (2007) Indications for orthoses to improve gait in children with cerebral palsy. J Am Acad Orthop Surg 15(3):178–188

    PubMed  Google Scholar 

  8. De Lissovoy G, Matza LS, Green H et al (2007) Cost-effectiveness of intrathecal baclofen therapy for the treatment of severe spasticity associated with cerebral palsy. J Child Neurol 22(1):49–59

    Article  Google Scholar 

  9. Desloovere K, Molenaers G, De Cat J et al (2007) Motor function following multilevel botulinum toxin type A treatment in children with cerebral palsy. Dev Med Child Neurol 49(1):56–61

    PubMed  Google Scholar 

  10. Döderlein L (Hrsg) (2007) Infantile Zerebralparesen. Operative Behandlungsverfahren. Steinkopff, Heidelberg, S 185–207

  11. Edgar TS (2003) Oral pharmacotherapy of childhood movement disorders. J Child Neurol [Suppl 1] 18:S40–S49

    Google Scholar 

  12. Eliasson AC (2005) Improving the use of hands in daily activities: aspects of the treatment of children with cerebral palsy. Phys Occup Ther Pediatr 25(3):37–60

    Article  PubMed  Google Scholar 

  13. Fuchs A, Döderlein L (2004) Orthopädietechnik und ICP. Orthopade 33:1173–1182

    Article  PubMed  CAS  Google Scholar 

  14. Hagglund G, Andersson S, Düppe H et al (2005) Prevention of dislocation of the hip in children with cerebral palsy. The first ten years of a population-based prevention programme. J Bone Joint Surg Br 87(1):95–101

    Article  PubMed  CAS  Google Scholar 

  15. Hagglund G, Lauge-Pedersen H, Wagner P (2007) Characteristics of children with hip displacement in cerebral palsy. BMC Musculoskelet Disord 8:101

    Article  PubMed  Google Scholar 

  16. Heinen F, Molenaers G, Fairhurst C et al (2006) European consensus table 2006 on botulinum toxin for children with cerebral palsy. Eur J Paediatr Neurol 10(5–6):215–225

    Google Scholar 

  17. Hoving MA, Van Raak EP, Spincemaille GH et al (2007) Intrathecal baclofen in children with spastic cerebral palsy: a double-blind, randomized, placebo-controlled, dose-finding study. Dev Med Child Neurol 49(9):654–659

    Article  PubMed  Google Scholar 

  18. Kolaski K, Logan LR (2007) A review of the complications of intrathecal baclofen in patients with cerebral palsy. NeuroRehabilitation 22(5):383–395

    PubMed  Google Scholar 

  19. Koman LA, Smith BP, Shilt JS (2004) Cerebral palsy. Lancet 363(9421):1619–1631

    Article  PubMed  Google Scholar 

  20. Krageloh-Mann I, Horber V (2007) The role of magnetic resonance imaging in elucidating the pathogenesis of cerebral palsy: a systematic review. Dev Med Child Neurol 49(2):144–151

    Article  PubMed  Google Scholar 

  21. Krageloh-Mann I, Hagberg G, Meisner C et al (1994) Bilateral spastic cerebral palsy – a comparative study between southwest Germany and Western Sweden. II: Epidemiology. Dev Med Child Neurol 36(6):473–483

    Article  PubMed  CAS  Google Scholar 

  22. Molenaers G, Desloovere K, Fabry G et al (2006) The effects of quantitative gait assessment and botulinum toxin A on musculoskeletal surgery in children with cerebral palsy. J Bone Joint Surg Am 88(1):161–170

    Article  PubMed  Google Scholar 

  23. Nemer McCoy R, Blasco PA, Russman BS et al (2006) Validation of a care and comfort hypertonicity questionnaire. Dev Med Child Neurol 48(3):181–187

    Article  Google Scholar 

  24. O’Flaherty S, Waugh MC (2003) Pharmacologic management of the spastic and dystonic upper limb in children with cerebral palsy. Hand Clin 19(4):585–589

    Article  Google Scholar 

  25. Palisano R, Rosenbaum PL, Walter S et al (1997) Development and reliability of a system to classify gross motor function in children with cerebral palsy. Dev Med Child Neurol 39(4):214–223

    PubMed  CAS  Google Scholar 

  26. Pin T, Dyke P, Chan M (2006) The effectiveness of passive stretching in children with cerebral palsy. Dev Med Child Neurol 48(10):855–862

    Article  PubMed  Google Scholar 

  27. Platt MJ, Cans C, Johnson A et al (2007) Trends in cerebral palsy among infants of very low birth weight (<1500 g) or born prematurely (<32 weeks) in 16 European centres: a database study. Lancet 369(9555):43–50

    Article  PubMed  Google Scholar 

  28. Rosenbaum P, Walter SD, Hanna SE et al (2002) Prognosis for gross motor function in cerebral palsy: creation of motor development curves. JAMA 288(11):1357–1363

    Article  PubMed  Google Scholar 

  29. Rosenbaum P, Paneth N, Leviton A et al (2007) A report: the definition and classification of cerebral palsy April 2006. Dev Med Child Neurol [Suppl] 109:8–14

    Google Scholar 

  30. Russell D, Rosenbaum P, Avery L et al (2006) GMFM und GMFCS Messung und Klassifikation motorischer Funktionen. Huber, Bern

  31. SCPE (2000) Surveillance of cerebral palsy in Europe: a collaboration of cerebral palsy surveys and registers. Surveillance of Cerebral Palsy in Europe (SCPE). Dev Med Child Neurol 42(12):816–824

    Google Scholar 

  32. SCPE (2002) Prevalence and characteristics of children with cerebral palsy in Europe. Dev Med Child Neurol 44(9):633–640

    Google Scholar 

  33. Simpson DM, Gracies JM, Graham HK et al (2008) Assessment: Botulinum neurotoxin for the treatment of spasticity (an evidence-based review): report of the therapeutics and technology assessment subcommittee of the American Academy of Neurology. Neurology 70(19):1691–1698

    Article  PubMed  CAS  Google Scholar 

Download references

Interessenkonflikt

Keine Angaben.

Author information

Authors and Affiliations

  1. Abteilung für Pädiatrische Neurologie und Entwicklungsneurologie, Dr. von Haunersches Kinderspital, Ludwig-Maximilians-Universität München, Lindwurmstraße 4, 80337, München, Deutschland

    F. Heinen, A.S. Schröder, I. Borggräfe, K. Huss, U. Breuer & B. Warken

  2. Orthopädische Kinderklinik, Behandlungszentrum Aschau, Aschau, Deutschland

    L. Döderlein

  3. Sozialpädiatrisches Zentrum, Kinderkrankenhaus auf der Bult, Hannover, Deutschland

    W. Voss

  4. Sozialpädiatrisches Zentrum, Städtische Kliniken Frankfurt-Höchst, Frankfurt, Deutschland

    U. Hustedt

  5. Klinik II Neuropädiatrie und Muskelerkrankungen, Zentrum für Kinder- und Jugendmedizin, Universitätsklinikum Freiburg, Freiburg, Deutschland

    V. Mall

  6. Stiftung Orthopädische Universitätsklinik, Heidelberg, Deutschland

    B. Wiedenhöfer

  7. Zentrum für Muskulo-skelettale Erkrankungen und Verletzungen, Krankenhaus Rummelsberg, Rummelsberg, Deutschland

    G. Manolikakis

  8. Haus Walstedde, Gesundheitszentrum für Kinder, Jugendliche und junge Erwachsene, Drensteinfurt, Deutschland

    A. Sprinz

  9. Neurologische Rehabilitationsklinik Beelitz-Heilstätten, Beelitz-Heilstätten, Deutschland

    J. Wissel

  10. Praxis für Orthopädie, Bad Neuenahr-Ahrweiler, Deutschland

    K.E. Behrens

  11. Klinik für Neurologie und Poliklinik, Universität Rostock, Rostock, Deutschland

    R. Benecke

  12. Neurologisches Krankenhaus, München, Deutschland

    U.M. Fietzek

  13. Deutscher Verband für Physiotherapie, Zentralverband der Physiotherapeuten/Krankengymnasten, München, Deutschland

    B. Böhle

  14. Neuropädiatrie, Entwicklungsneurologie, Sozialpädiatrie (Abteilung III), Universitätsklinik für Kinder- und Jugendmedizin, Tübingen, Deutschland

    I. Krägeloh-Mann & S. Berweck

Authors
  1. F. Heinen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A.S. Schröder
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. L. Döderlein
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. W. Voss
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. U. Hustedt
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. V. Mall
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. I. Borggräfe
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. B. Wiedenhöfer
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. G. Manolikakis
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. K. Huss
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. A. Sprinz
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. J. Wissel
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. K.E. Behrens
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. R. Benecke
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. U.M. Fietzek
    View author publications

    You can also search for this author in PubMed Google Scholar

  16. U. Breuer
    View author publications

    You can also search for this author in PubMed Google Scholar

  17. B. Warken
    View author publications

    You can also search for this author in PubMed Google Scholar

  18. B. Böhle
    View author publications

    You can also search for this author in PubMed Google Scholar

  19. I. Krägeloh-Mann
    View author publications

    You can also search for this author in PubMed Google Scholar

  20. S. Berweck
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to F. Heinen.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Heinen, F., Schröder, A., Döderlein, L. et al. Grafikgestützter Konsensus für die Behandlung von Bewegungsstörungen bei Kindern mit bilateralen spastischen Zerebralparesen (BS-CP). Monatsschr Kinderheilkd 157, 789–794 (2009). https://doi.org/10.1007/s00112-009-2001-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00112-009-2001-2

Schlüsselwörter

Keywords

Search

Navigation